Enhanced CEO outlines business strategy ahead of May games launch
Enhanced (NYSE: ENHA) CEO Maximilian Martin published a shareholder letter detailing the company's dual business model combining elite sports competition with consumer health products, according to a company statement.
The company will host its inaugural Enhanced Games on May 24, 2026, at Resorts World in Las Vegas. The event will feature a 2,500-seat purpose-built competition complex and will be streamed for free on multiple platforms. Van Wagner, which produces the Super Bowl and Kentucky Derby, serves as the production partner.
Enhanced operates two business segments: the Enhanced Games sporting events and the Live Enhanced consumer platform. The sporting business generates revenue primarily from sponsorships, while the consumer platform offers supplements and telehealth services including hormone replacement therapy and FDA-approved peptides.
The company's medical program operates as an Institutional Review Board clinical study overseen by Independent Medical and Scientific Commissions. Athletes can choose whether to use performance enhancements, with all substances being FDA-approved. Non-enhanced athletes receive the same medical care and compensation.
Enhanced completed a business combination with A Paradise Acquisition Corp. (NASDAQ: APAD) in November 2025 to access public capital markets. The company reported that its content has been viewed over 600 million times since announcing its first enhanced world record in May 2025.
Greek Olympian Kristian Gkolomeev broke the 50-meter freestyle swimming world record in February 2025 as the first openly enhanced athlete, earning a $1 million bonus from Enhanced.
The Live Enhanced platform currently offers two supplement stacks and telehealth services spanning hormone replacement therapy, testosterone replacement therapy, longevity drugs and peptides. The company plans to introduce personalized supplement offerings this summer.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA clears Dexcom's over-the-counter glucose monitor for children
- AMETEK secures $7.5 billion in credit facilities for Indicor acquisition
- FDA clears first over-the-counter glucose monitor for children
Create E-mail Alert Related Categories
Corporate News, Management CommentsRelated Entities
Definitive Agreement, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share